Role of UBE2C in Brain Cancer Invasion and Dissemination
Open Access
- 31 October 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (21) , 15792
Abstract
Glioblastoma (GB) and brain metastases (BM) are the most common brain tumors in adults and are invariably associated with a dismal outcome. These highly malignant tumors share common features including increased invasion and migration of the primary or metastatic brain cancer cells, whose triggering mechanisms are largely unknown. Emerging evidence has suggested that the ubiquitin-conjugating enzyme E2C (UBE2C), essential for controlling cell cycle progression, is overexpressed in diverse malignancies, including brain cancer. This review highlights the crucial role of UBE2C in brain tumorigenesis and its association with higher proliferative phenotype and histopathological grade, with autophagy and apoptosis suppression, epithelial-to-mesenchymal transition (EMT), invasion, migration, and dissemination. High expression of UBE2C has been associated with patients’ poor prognosis and drug resistance. UBE2C has also been proven as a promising therapeutic target, despite the lack of specific inhibitors. Thus, there is a need to further explore the role of UBE2C in malignant brain cancer and to develop effective targeted therapies for patients with this deadly disease.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (2022.08774.PTDC, 2023.03882.BD, 17859)
- Portugal Programa Gilead GÉNESE (2022.08774.PTDC, 2023.03882.BD, 17859)
This publication has 126 references indexed in Scilit:
- Identification of small molecule inhibitors against UBE2C by using docking studiesBioinformation, 2012
- Immunohistochemical Analysis of the Ubiquitin-conjugating Enzyme UbcH10 in Lung CancerJournal of Histochemistry & Cytochemistry, 2012
- CCI-779 Inhibits Cell-Cycle G2–M Progression and Invasion of Castration-Resistant Prostate Cancer via Attenuation of UBE2C Transcription and mRNA StabilityCancer Research, 2011
- Spindle Assembly Checkpoint Protein Cdc20 Transcriptionally Activates Expression of Ubiquitin Carrier Protein UbcH10Journal of Biological Chemistry, 2011
- Bortezomib Stabilizes Mitotic Cyclins and Prevents Cell Cycle Progression via Inhibition of UBE2C in Colorectal CarcinomaThe American Journal of Pathology, 2011
- Overexpression of the E2 ubiquitin–conjugating enzyme UbcH10 causes chromosome missegregation and tumor formationJournal of Cell Biology, 2010
- Identification of Survival Genes in Human Glioblastoma Cells by Small Interfering RNA ScreeningMolecular Pharmacology, 2009
- WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma MetastasisCell, 2009
- Genes that mediate breast cancer metastasis to the brainNature, 2009
- The Processivity of Multiubiquitination by the APC Determines the Order of Substrate DegradationCell, 2006